Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Immunic, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 50 | −3 |
| Shares | 18.4M | 272.5K | 15.1M | −2.96M (−16.4%) |
| Value | $27.0M | $400.5K | $22.7M | −$3.90M (−14.6%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Immunic, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 328,699 | $493.0K | 0.42% |
| Sierra Summit Advisors LLC | 324,829 | $487.2K | 0.14% |
| Sweet Financial Partners, LLC | 29,829 | $44.7K | 0.01% |
| Wolverine Trading, LLC | 10,925 | $16.4K | 0.00% |
| Private Advisor Group, LLC | 10,000 | $15.0K | 0.00% |
| BFSG, LLC | 3,000 | $4.50K | 0.00% |
| Federated Hermes, Inc. | 614 | $921 | 0.00% |
Sold out (10)
Institutions that held Immunic, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| BVF Inc | 1,149,425 | $1.69M |
| Ikarian Capital, LLC | 450,000 | $661.5K |
| Verition Fund Management LLC | 245,308 | $360.6K |
| Millennium Management LLC | 106,215 | $156.1K |
| Connor, Clark & Lunn Investment Management Ltd. | 24,773 | $36.4K |
| Denali Advisors LLC | 17,000 | $25.0K |
| LPL Financial LLC | 11,000 | $16.2K |
| FMR LLC | 3,577 | $5.26K |
| Buck Wealth Strategies, LLC | 450 | $662 |
| Group One Trading, L.P. | 428 | $629 |
Not filed for Q4 2023 yet (1)
Institutions that held Immunic, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Innovis Asset Management LLC | 272,457 | $400.5K |